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Signal transductionSyk is a 72-kDa protein-tyrosine kinase that regulates signaling throughmultiple cell surface receptors including
those for antigens, immunoglobulins and proteins of the extracellular matrix. As part of its function, Syk binds a
variety of downstream effectors through interactions that are oftenmediated bymotifs that recognize phospho-
tyrosines. In a search for novel Syk-interacting proteins by yeast two-hybrid analysis, we identiﬁed tensin2 as a
Syk-binding protein. Syk interacts with a fragment of tensin2 located near the C-terminus that contains SH2 and
PTB domains. In epithelial cells, tensin2 localizes both to focal adhesions and to large cytoplasmic puncta. It is
within these punctuate structures that Syk and tensin2 are co-localized. The clustering of Sykwithin these struc-
tures leads to its phosphorylation on tyrosine.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Syk is a 72-kDa nonreceptor, protein-tyrosine kinase best character-
ized as a modulator of immune cell function through its associations
with immune recognition receptors. In a variety of hematopoietic cell
types, Syk couples receptors for antigens and immunoglobulins to multi-
ple intracellular signalingpathways activatedduringhost/pathogen inter-
actions [1,2]. In recent years Syk also has been identiﬁed in an increasingly
wide variety of nonhematopoietic cells [3]. These include epithelial cells,
endothelial cells, hepatocytes, melanocytes, nasal ﬁbroblasts, vascular
smoothmuscle cells and neuronal cells. Syk has been described as having
a number of functions in these cells including the regulation of mitosis,
differentiation, cellular adhesion and motility. Syk functions both as a
catalyst for the phosphorylation of protein substrates and as a scaffold
for promoting protein–protein interactions, often involving proteins
with SH2 or other phosphotyrosine interactingmotifs that bind to speciﬁc
phosphotyrosines on Syk [1,2]. Since these associated proteins and
substrates are critical effectors that mediate signaling through
Syk-associated receptors, there is considerable interest in their identiﬁca-
tion and characterization. A few examples of Syk-binding proteins that
have been reported and studied are Vav, Cbl, PLC-γ, PI3K, Fgr, TRIP, and
USP25 [1,2,4].
As part of our analysis of Syk-interacting proteins, we carried out two
yeast two-hybrid screens using libraries derived either from human bone
marrowormammary gland [5,6]. In both screenswe identiﬁed tensin2 asemistry andMolecular Pharma-
ayette, IN 47907, USA. Tel.: +1
.
rights reserved.a Syk-interacting protein. Tensin2 is a member of a family of related
cytoskeletal proteins that includes tensin1, tensin2/TENC1, tensin3 and
tensin4/CTEN that modulate both cell motility and transformation [7].
Tensin2 was identiﬁed previously as a binding partner of a different
kinase, the receptor tyrosine kinase Axl [8]. Like other tensin-family
members, tensin2 possesses C-terminal Src-homology 2 (SH2) and phos-
photyrosine binding [PTB) domains, and itwaswithin this region that Axl
binds. These domains also target tensin proteins to focal adhesions by
binding to β integrins and mediate their interactions with DLC1 (deleted
in liver cancer-1), a tumor suppressor and negative regulator of
Rho-family GTPases [9–12]. We ﬁnd that this region also mediates the
interaction of tensin2 with Syk.
2. Materials and methods
2.1. Cells and antibodies
Syk-deﬁcientMCF-7 cells and DT40 cells line stably expressingMyc-
tagged Syk were described previously [13,14]. NIH 3T3 cells were
obtained from American Type Culture Collection. HMEC-1 cells were
obtained from the Centers for Disease Control. The monoclonal anti-
body against the Myc-epitope (9B11) was from Cell Signaling Technol-
ogy. Antibodies against GST and Syk (N19) were purchased from Santa
Cruz Biotechnology. The antibody against vinculin (hVIN-1) was
obtained from Sigma. To generate an antibody against tensin2, the
cDNA coding for amino acids 880–980 was PCR-ampliﬁed and inserted
into the pGEX2T bacterial expression plasmid. The GST–tensin2 fusion
protein was expressed in bacteria, puriﬁed by afﬁnity chromatography
on glutathione-Sepharose and used as an antigen for the generation of
rabbit immune serum using a commercial service (Lampire Biological
Laboratories).
Fig. 1. Syk interacts with tensin2 in a yeast two-hybrid screen. (A) Schematic diagram of
full-length tensin2 and of the two C-terminal fragments identiﬁed in the two-hybrid
screen. The number indicates the amino acid residue at the N-terminus of each fragment.
(B) Gal4 DNA binding domain-fusion proteins containing Syk, the kinase dead
Syk(K396R) mutant (KD), or the p53 protein were examined in a yeast two-hybrid
assay for binding to the tensin2 fragment starting at residue 917 (TNS2), full-length Fgr
or the C-terminal SH2 domain of p85. Growth of yeast colonies was measured on His
and Ade double deﬁcient plates. (C) Gal4 DNA binding domain-fusion proteins containing
Syk, the kinase dead mutant (KD), or the tandem SH2 domains ((SH2)2) were examined
in a yeast two-hybrid assay for binding to tensin2 fragments starting at residue 917 or
1032. Growth of yeast colonies was measured on His and Ade double deﬁcient plates.
Fig. 2. Syk interacts with tensin2, but not tensin1. (A) Gal4 DNA binding domain-fusion
proteins containing Syk or only the Syk kinase domain (Syk K) were examined in a
yeast two-hybrid assay for binding to the tensin2 C-terminal fragment starting at residue
917 (TNS2), the tensin2 PTB domain (PTB) or a tensin1 C-terminal fragment encompass-
ing residues 1340–1736 (TNS1). (B) A Gal4 DNA binding domain-fusion protein contain-
ing Syk was examined in a yeast two-hybrid assay for binding to the tensin2 C-terminal
fragment starting at residue 917 (TNS2), a tensin1 C-terminal fragment encompassing
residues 1340–1736 (TNS1) the tensin1 fragment in which the N-terminal 115 amino
acids were replaced by residues 917–1032 from tensin2 (TNS2–1). Growth of yeast
colonies was measured on His and Ade double deﬁcient plates.
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Analyses by yeast two-hybrid screens of Syk-interacting proteins
from human bone marrow and human mammary gland libraries were
as described previously [5,6]. The plasmids pACT2–tensin2(PTB
domain), pACT2–tensin2–tensin1, and pACT2–tensin1 were prepared
by in-frame insertion of the desired cDNAs by standard PCR and DNA
manipulation techniques. A cDNA encoding an HA-tagged C-terminal
fragment of tensin2 (amino acids 936–1419) was PCR-ampliﬁed and
inserted into the pFastBAC plasmid, which was then transformed into
DH10bac cells (Gibco-BRL/Invitrogen) for generating the recombinant
baculovirus. Baculoviruses for the expression of GST–Syk fusion
proteins were described previously [15,16]. GST–fusion proteins were
puriﬁed from cell lysates by adsorption onto glutathione-Sepharose.
The vector for the expression of Syk tagged at the C-terminus with a
Myc-epitope in DT40 B cells was as described [14]. HA-tagged proteins
were isolated by adsorption onto protein A-Sepharose beads containing
a bound HA antibody. Sf9 insect cells expressing GST–Syk fusion
proteins or Syk-deﬁcient DT40 B cells expressing Syk–Myc were lysed
in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM EDTA,
1% NP40, and 10 μg/ml each of aprotinin and leupeptin. Proteins in
cell lysates were adsorbed to beads containing immobilized proteins.
Bound proteins were separated by SDS-PAGE and detected by Western
blotting using enzyme-linked chemiluminescence (ECL) reagents
(Amersham Biosciences).
2.3. Fluorescence microscopy
MCF7 cells transiently transfected to express Syk–EGFP, EGFP–ten-
sin2 or Myc–tensin2 were cultured on coverslips, ﬁxed with 3.7% form-
aldehyde for 5 min, permeabilizedwith 1% Triton X-100 in PBS, blocked
in PBS containing 1 mg/ml BSA, 0.05% Tween 20 and 10% goat serum
and stained with antibodies against the Myc epitope or vinculin.
Bound primary antibodies were detected using a Texas red-
conjugated donkey anti-mouse antibody (Jackson Immunoresearch).
Plasmids for the expression of Myc–tensin2 and EGFP–tensin2 were
generously supplied by Drs. Sassan Haﬁzi (Lund University) and Su
Hao Lo (University of California at Davis). The plasmid coding for Syk–
EGFP was described previously [17].
3. Results
3.1. Syk interacts with tensin2 in a yeast two-hybrid assay
As part of our efforts to characterize the Syk interaction network, we
carried out yeast two-hybrid protein interaction screens in search of
proteins capable of interacting with Syk [5,6]. We used full-length Syk
as bait and as prey, proteins coded by cDNA libraries representing
human bone marrow or, in a second screen, human mammary gland.
Both interaction screens identiﬁed tensin2 as a Syk-interacting protein.
In these screens, tensin2 failed to interact with p53,whichwas used as a
negative control.
Positive clones from each library coded for the C-terminus of ten-
sin2. This region contains both an SH2 domain and a PTB domain
(Fig. 1A), suggesting that an interaction with Syk might be mediated
by phosphotyrosine. Syk, when expressed in yeast as a fusion protein
with the GAL4 DNA-binding domain, is known to catalyze an autopho-
sphorylation reaction, allowing it to interact with SH2 domain-
containing proteins that bind to phosphotyrosines [5,6,18]. To examine
the dependence of the Syk–tensin2 interaction on the status of Syk's
phosphorylation, we probed the interaction again using a catalytically
inactive form of Syk (Syk(K396R)) incapable of catalyzing autopho-
sphorylation. Fgr and p85 (the regulatory subunit of phosphoinositide
3-kinase), which have SH2 domains known to interact selectively
with phosphorylated Syk (and hence with Syk, but not Syk(K396R))
[5,19], were used as positive controls. Interestingly, the ability oftensin2 to interact with catalytically active versus inactive Syk
depended on the length of the C-terminal fragment. The longest version
of the tensin2 C-terminus was able to interact with both Syk and
Syk(K396R), indicating a mode of interaction independent of Syk's
phosphorylation on tyrosine. Neither Fgr nor p85 bound to the catalyt-
ically inactive Syk (Fig. 1B). However, a shorter C-terminal fragment of
tensin2 lacking amino acid residues 917–1032, which lie just upstream
of the SH2 domain, failed to interact with Syk(K396R), but still bound to
catalytically active Syk (Fig. 1C). Thus, the C-terminal SH2+PTB do-
mains of tensin2 have the ability to bind to Syk, but likely do so only
when the kinase is phosphorylated on one or more tyrosines. Removal
of the SH2 domain from this construct abolished the interaction, sug-
gesting that it is the tensin2 SH2 domain that interacts with one or
more phosphotyrosines on Syk (Fig. 2A). Tensin2was unable to interact
in the two-hybrid screenwith either a truncated form of Syk containing
only the pair of N-terminal tandemSH2domains or a construct contain-
ing only the catalytic domain (Figs. 1C and 2A).
Fig. 3. Syk interacts with tensin2 in pull-down assays. (A) Lysates fromDT40 cells expres-
sing. Myc-tagged Syk were adsorbed to protein A-Sepharose containing either an HA-
tagged C-terminal fragment of tensin2 bound to an antibody against HA (HA–TNS2), an
antibody against the Myc-epitope (α-Myc) or no bound antibody (Ctrl). The presence of
Syk bound to the beads was detected by Western blot (WB) using an antibody against
Syk. (B) GST–Syk (Syk), GST–Sykp42.5 (p42), and GST–Sykp35 (p35) fusion proteins
were isolated from insect cell lysates by adsorption to glutathione-agarose and detected
byWestern blotting with antibodies against GST. (C) Lysates from insect cells expressing
(+) or not expressing (−) the HA–tensin2 C-terminal fragment were adsorbed to
glutathione-agarose containing bound GST–Syk (Syk), GST–Sykp42.5 (p42), GST–
Sykp35 or, as a control, GST linked to the SH2 domain of PLC-γ (PLC). Bound protein
was detected by Western blot (WB) using an antibody against HA. (D) Puriﬁed GST–Syk
(Syk), GST–Sykp42.5 (p42) or GST–Sykp35 (p35) were incubated with HA–tensin2
bound to an anti-HA antibody immobilized on protein A-Sepharose. The presence of the
fusion protein in each HA-immune complex was detected by Western blotting (WB)
using an anti-GST antibody.
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Tensin2 shares considerable sequence similaritywith tensin1 (tensin)
in both the N- and C-termini, including the SH2 and PTB domains, while
the internal regions of each are unique [7]. To determine if tensin1 shared
an abilitywith tensin2 to interactwith Syk,we ampliﬁed the cDNAcoding
for amino acids 1340–1736 of tensin1 (corresponding to the largest frag-
ment of tensin2 identiﬁed by the yeast two-hybrid screen) and used this
for interaction assays in the yeast two-hybrid system. Interestingly, the
tensin1 C-terminus failed to bind to Syk (Fig. 2A). The 115 amino acids lo-
cated upstream of the tensin2 SH2 domain differ from those found in the
tensin1 fragment. Replacement of the unique tensin1 sequence with the
corresponding sequence from tensin2 (917–1032) failed to convert the
tensin1 C-terminus into a Syk-binding protein (Fig. 2B). Thus, the interac-
tion with Syk appears to be speciﬁc for tensin2 as opposed to tensin1.
3.3. Syk interacts with tensin2 in pull-down assays
To obtain further evidence for a direct interaction between tensin2
and Syk, we used biochemical approaches. We ﬁrst generated a recom-
binant baculovirus for the expression in insect cells of an HA-tagged
form of tensin2 consisting of the C-terminal region determined to
bind Syk in the two-hybrid assay. HA–tensin2was immunoprecipitated
from lysates of infected insect cells with an HA antibody bound to pro-
tein A-Sepharose. The immobilized HA–tensin2was then used in a pull-
down assay to recover Syk from Syk-deﬁcient chicken DT40 B cells
transfected to express a Myc epitope-tagged form of murine Syk. The
presence of Syk in the immune complex was detected by an anti-Syk
antibody. The immobilized, tagged tensin2 protein was able to recover
Myc–Syk from the cell lysate, further conﬁrming the ability of these
two proteins to interact (Fig. 3A). The anti-Syk antibody also detected
the epitope-tagged protein in an anti-Myc immune complex.
In a related experiment, we adsorbed lysates from insect cells
infected to express HA–tensin2 to glutathione-agarose beads to which
were bound various forms of Syk: GST–Syk (full-length kinase), GST–
Sykp42.5 (catalytic domain plus entire linker B region) or GST–Sykp35
(catalytic domain lacking most of linker B). We found that HA–tensin2
interacted with GST–Syk and GST–Sykp42.5, but not GST–Sykp35
(Fig. 3C). In a reciprocal experiment, these same GST fusion proteins
were adsorbed to anti-HA immune complexes recovered from insect
cells expressing the HA–tensin2 fragment. Bound proteins were recov-
ered, separated by SDS-PAGE and detected by Western blotting with
antibodies against GST. Again, GST–Syk and GST–Sykp42.5, but not
GST–Sykp35 interacted with HA–tensin2 (Fig. 3D). These results indi-
cate that the interaction of tensin2with Syk is likely to require the linker
B region of Syk including the 100 residues between amino acids 256 and
327.
3.4. Localization of tensin2 in MCF7 cells
To explore further a possible interaction between Syk and tensin2
and to examine where within a cell the two proteins might interact,
we ﬁrst examined the localization of the two proteins by expressing
tagged versions of each. We used cultured MCF7 mammary epithelial
cells since tensin2 was detected as a Syk-interacting protein using a
mammary gland cDNA library and has been reported to be phosphory-
lated on tyrosine in mammary epithelial cells [20]. For these experi-
ments we used a clone of MCF7 cells described previously that lacks
endogenous Syk [13]. When expressed in conﬂuent MCF7 cells, GFP–
tensin2 appeared in large, brightly staining bodieswithin the cytoplasm
(Fig. 4A). We found a similar distribution of tensin2 in cells transfected
with aMyc-epitope tagged formof the protein and stainedwith an anti-
Myc antibody (Fig. 4A). Thus, it was unlikely that the GFP tag alone had
altered the subcellular distribution of the protein. To examine cells for
the localization of endogenous tensin2, we generated polyclonal anti-
bodies against a GST fusion protein containing the region of tensin2between amino acids 880 and 980. As tensin2 is expressed at higher
levels in endothelial cells, we ﬁxed and stained HMEC-1 human micro-
vascular endothelial cells with tensin2 antisera (Fig. 4A). Again tensin2
exhibited a punctate distribution throughout the cell. This distribution
closely resembles the distribution of tensin2 reported previously in
DU145 prostate adenocarcinoma cells [21].
Previous studies on the localization of tensin2 in ﬁbroblasts, however,
described the protein as resident in focal adhesions [22,23]. To conﬁrm
this result, we transfected NIH 3T3 cells with the expression construct
for GFP–tensin2 and examined the cells under a ﬂuorescencemicroscope.
Consistent with previous analyses, a fraction of the GFP–tensin2 was
found in a punctate distribution at the cell periphery consistent with
localization to focal adhesions (data not shown). To determine if tensin2
also could localize to focal adhesions inmammary epithelial cells,weplat-
ed MCF7 cells transfected to express GFP–tensin2 at a low density since
conﬂuent cells exhibit few peripheral focal adhesions. Under these
growth conditions, a fraction of GFP–tensin2 could indeed be visualized
in punctate structures localized at the cell periphery (Fig. 4B). The identi-
ﬁcation of these structures as focal adhesions was veriﬁed by co-staining
transfected cells with antibodies against vinculin. Thus, tensin2 also local-
izes to focal adhesions in epithelial cells. However, much of the expressed
GFP–tensin2 in subconﬂuent MCF7 cells was still present in what
appeared to be large clusters in the cytoplasm.
We were concerned that these large clusters might represent insol-
uble aggregates of overexpressed protein, so we asked if the tensin2
within these bodies retained the ability to localize to focal adhesions.
The number of stable focal adhesions can be increased by treating
cells with agents that depolymerize microtubules [24,25]. This inhibits
the microtubule-induced disassembly of focal adhesion complexes. In
MCF7 cells treated with nocodazole, GFP–tensin2 relocalized from the
cytoplasmic clusters to these stabilized focal adhesions (Fig. 4C). This
result indicates that the tensin2 molecules present in the cytoplasmic
Fig. 4. Syk and tensin2 co-localize in cytoplasmic punctate bodies. (A)MCF7 cellswere transiently transfectedwith plasmids expressingGFP–tensin2 (GFP–TNS2) orMyc–tensin2 (Myc–TNS2).
Cells expressing GFP–TNS2 were ﬁxed and examined by ﬂuorescence microscopy. Cells expressing Myc–TNS2 were ﬁxed, permeabilized and stained with a Myc antibody and a ﬂuores-
cently tagged secondary antibody. HMC1 cells were ﬁxed, permeabilized and stainedwith an antibody against tensin2 and a ﬂuorescently tagged secondary antibody. (B)MCF7 cells tran-
siently expressing GFP–tensin2 (GFP–TNS2)were ﬁxed, permeabilized and stainedwith an antibody against vinculin and a ﬂuorescently tagged secondary antibody. Examples of tensin2
and vinculin co-localized to focal adhesions are illustrated by arrows in the merged image. (C) MCF7 cells transiently expressing GFP–tensin2 were treated without (− nocod) or with
(+ nocod) nocodazole, ﬁxed and examined by ﬂuorescence microscopy. The microscope is focused on the basolateral surface of the cells. (D) MCF7 cells were transiently transfected
with plasmids coding for Syk–EGFP and Myc–tensin2. Cells were ﬁxed, permeabilized and stained with anti-Myc and a ﬂuorescently tagged secondary antibody. Merged images are
shown in the third panel. (E) MCF7 cells expressing Syk–EGFP were examined by ﬂuorescence microscopy. Bars represent 10 μm.
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readily redistribute to focal adhesions.
3.5. Syk co-localizes with tensin2 in cytoplasmic puncta
When expressed in MCF7 breast epithelial cells, Syk–EGFP was pre-
sent throughout the cell as described previously [13]. Some Syk–EGFP
does redistribute to the cell periphery in breast epithelial cells spread-
ing on surfaces coated with ﬁbronectin, but does not obviously localize
to focal adhesions [13]. The co-expression of Myc–tensin2 with Syk–
EGFP caused a marked redistribution of Syk–EGFP from its normal, dif-
fuse distribution (Fig. 4E) to punctuate structures in the cytoplasmwhere it co-localized with Myc–tensin2 (Fig. 4D). These data indicate
that Syk and tensin2 retain the ability to interact when expressed in
living cells. We did not, however, observe a localization of Syk with
tensin2 in focal adhesions.
3.6. Binding of Syk to tensin2 leads to its phosphorylation on tyrosine
The binding of tensin2 to Syk could inhibit its activity. Conversely,
the aggregation of Syk could lead to its activation via its enhanced phos-
phorylation on tyrosine. To examine the effects of tensin2 expression on
the phosphorylation status of Syk, we expressed Syk–EGFP in the pres-
ence or absence of exogenous tensin2 in the Syk-deﬁcientMCF7 cells. In
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sion of tensin2 with either EGFP or Myc-epitope tags. Cell lysates were
then separated by SDS-PAGE and analyzed by Western blotting using
antibodies against Syk, tensin2 and phosphotyrosine. The extent of
phosphorylation of Syk–EGFP on tyrosine was elevated in the cells in
which tensin2 also was expressed (Fig. 5). These studies suggest that
Syk is activated following tensin2 induced clustering of the kinase. We
did not observe a phosphotyrosine-containing protein band migrating
at the position of either Myc–tensin2 or GFP–tensin2. When we ana-
lyzed either anti-Myc or anti-GFP immune complexes isolated from
cells also expressing Syk–EGFP, we could readily detect the tensin2
fusion proteins with anti-tensin2 antibodies by Western blotting, but
were unable to detect the presence of phosphotyrosine on either pro-
tein using antibodies against phosphotyrosine (data not shown). Thus,
it seems unlikely that tensin2 is robustly phosphorylated by Syk.
4. Discussion
In this study, we report for the ﬁrst time an interaction between the
tyrosine kinase Syk and the cytoskeletal protein tensin2. Most proteins
that have been found to associate with Syk do so via interactions medi-
ated by SH2 domains or related motifs (e.g., the SH2 domain of Vav1 or
p85, or the TKB domain of Cbl [5,18,26,27]) that bind phosphotyrosines.
Tensin2 also is capable of binding to Syk in this manner via a C-terminal
region that contains both an SH2 and a PTB domain. The interaction
with Syk of a short fragment of tensin2 consisting of the linked SH2
and PTB domains occurs only in screens inwhich the catalytically active
kinase is used as bait and not when an inactive enzyme is used. In pre-
vious screens, this has been correlated with a phosphotyrosine-
dependent interaction since only active Syk can catalyze an autopho-
sphorylation reaction when expressed in yeast [5,6]. Since removal of
the SH2 domain of tensin2 blocks this interaction, it is probable that it
is this domain that interactswith one ormore phosphotyrosines on Syk.
Interestingly, a larger fragment of the tensin2 C-terminus that
contains an addition of 115 amino acids just upstream of the SH2 domain
binds Syk independently of its state of phosphorylation as it interacts
nearly equally well with the catalytically active and inactive kinases.
This is an unusual mode of interaction for a Syk-binding protein.
USP25, a ubiquitin C-terminal hydrolase, also binds to Syk in a
phosphotyrosine-independent manner [4]. In this case, however,
USP25 binds to one of the Syk SH2 domains. We were unable to detect
an interaction of tensin2with anN-terminal fragment of Syk containing
only the tandem pair of SH2 domains in a yeast two-hybrid interaction
analysis. However, we were able to observe an interaction of USP25
with this construct (data not shown). Thus, USP25 and tensin2 bind
Syk by different mechanisms and do not share a common binding site.
Pull-down assays suggest instead that tensin2 interacts with residuesFig. 5. Expression of tensin2 enhances the phosphorylation of Syk on tyrosine. Syk-deﬁcient
MCF7 cellswere transiently transfectedwith the indicated amounts of plasmid (in μg) coding
for Syk–EGFP (Syk) and either GFP–tensin2 (GT2) orMyc–tensin2 (MT2). Protein expres-
sion and phosphorylationwasmeasured byWestern blotting using antibodies against Syk
(N19) (upper panel), phosphotyrosine (4G10) (middle panel) or tensin2 (antibodies de-
scribed in Section 2) (lower panel). Themigration positions of Syk (Syk), phospho-Syk (p-
Syk), GFP–tensin2 (GFP–TNS2) orMyc–tensin2 (Myc–TNS2) are indicated by arrows. The
relative extents of phosphorylation of Syk in the absence (normalized to a value of 1) or
presence of tensin2 are indicated under the antiphosphotyrosine Western blot.in linker B, which is the region of Syk that separates its pair of SH2
domains from the catalytic domain. It is within this region that most
known Syk-interacting proteins bind. It is not yet known how the
amino acids proximal to the SH2 domain of tensin2 confer on the
C-terminal fragment the ability to bind an inactive form of Syk.
In addition to Syk, the tyrosine kinase Axl has been shown to interact
with tensin2, also through its C-terminal SH2 and PTB domains [8]. The
yeast two-hybrid interaction screen using Axl as bait identiﬁed not only
tensin2 as a binding partner, but also the p85 subunit of PI3K, PLC-γ,
Nck and Grb2. Interestingly, all of these also are known to interact
with Syk or were observed in one or more of our two-hybrid screens.
Although Syk and Axl are both tyrosine kinases, they are not members
of closely related families as Axl is a receptor tyrosine kinase. Both,
however, can associate with and phosphorylate the IL-15 receptor, the
expression of both is associated with myeloid leukemia, and both are
known regulators of cell motility and cell survival [2,13,28–33]. It is
interesting to speculate that these similarities in function arise from
their related complement of binding partners.
The tensin2 C-terminal region also interacts with the tumor sup-
pressor DLC-1 [9–11]. Binding of DCL-1 independently to both the
SH2 and PTB domains has been described [9–11]. This interaction is in-
teresting as the phosphorylation of DCL-1 is not required for its binding
to the tensin2 SH2 domain [10]. While DCL-1 binds multiple members
of the tensin family including tensin1 [11], we were unable to demon-
strate an interaction between Syk and tensin1, indicating differences
in these two modes of binding. The binding of Syk with the C-terminal
portion of tensin1 could not be detected despite the 65% sequence sim-
ilarity between tensin1 and tensin2 within this fragment. Replacement
of the unique region just proximal to the SH2 domain of tensin1 with
the corresponding region of tensin2 failed to restore binding. These
results indicate a degree of speciﬁcity in the Syk/tensin2 interaction and
suggest that multiple tensin2 motifs participate in the phosphotyrosine-
independent binding of Syk.
In cells, Syk and tensin2 interactwithin large cytoplasmic structures.
This association alters the localization of Syk from its normally diffuse
distribution and enhances the phosphorylation of the kinase on tyro-
sine. The increased phosphorylation of Syk is an event that normally ac-
companies the activation of the kinase as is seen in B cells where
aggregation of the BCR leads to the co-clustering and activation of Syk
[1,2]. Syk, when phosphorylated on tyrosine, serves both as a catalyst
for further substrate phosphorylation and as a scaffold for the binding
of proteins containing SH2 or related phosphotyrosine interaction
motifs that include PLC-γ, PI3K and Vav1.We did not observe, however,
the phosphorylation of tensin2 on tyrosine in these complexes. Our
subsequent proteomic analyses of tyrosine phosphorylation in both B
cells and breast cancer cells also failed to identify tensin2 as a substrate
for Syk [34].
The nature of these cytoplasmic puncta is, as yet, unclear. An examina-
tion by confocal microscopy of multiple Z-sections from GFP–tensin2
expressing cells indicated that these puncta were localized throughout
the cell andwere not conﬁned to either the apical or basolateral surfaces.
A previous attempt to identify these cytoplasmic spots as speciﬁc intracel-
lular organelles such as endosomes or caveolae was unsuccessful [21]
(although a localization of tensin2 to caveolae has been observed [10]).
We also were unable to co-localize the tensin2-containing bodies with
markers of early or late endosomes or lysosomes. These cytoplasmic
structures do not seem to represent insoluble aggregates of protein,
however, as the tensin2 within these bodies is readily available for
recruitment to focal adhesions as indicated by its marked redistribution
following the treatment of cells with nocodazole. Thus, these structures
may represent a cytoplasmic pool of tensin2 available for recruitment to
focal adhesions once integrins are activated and engaged by extracellular
ligands. Thebindingof tensin-family proteinswith the cytoplasmic tails of
β integrins occurs via the C-terminal PTB domain, which binds indepen-
dently of tyrosine-phosphorylation [35,36]. One consequence of this relo-
calization is likely to be a change in cell migration as the ectopic
204 K.D. Moon et al. / Biochimica et Biophysica Acta 1823 (2012) 199–205expression of tensin2 has been reported to alter motility. However, both
positive and negative effects of tensin2 on motility have been described
[22,37,38], perhaps depending on cellular context, the exact isoform
that is expressed and the level of expression. It is interesting to note
that Syk is a negative regulator ofmotility in epithelial cells [13,39]. Unlike
DCL-1,which co-localizeswith tensin2 at focal adhesions [10,36],wehave
not observed a co-localization of Syk and tensin2 at these sites. However,
it is certainly possible that the sequestration of Syk from the cell periphery
could contribute to the ability of tensin2 to inﬂuence cell migration.
In addition to motility, tensin2 is also a modulator of cell survival, the
regulation of PI3K lipid reaction products and the activation of Akt
[9,11,37]. There are some indications that tensin2, due to its sequence
similarity with PTEN, has protein-tyrosine phosphatase activity and that
this underlies its inhibitory effects on cell survival [37,40]. However, a
comparison of the amino acid sequence surrounding the putative active
site cysteine of tensin2 (YCKGNKGKL) with that of the consensus
sequence for tyrosine/lipid phosphatases (HCXXGXXRS/T) indicates that
several key catalytic site residues are missing. Syk, in turn, is an upstream
activator of PI3K in antigen receptor and integrin signaling [41,42],
suggesting a possible connection between the sequestration of Syk or
other tyrosine kinases and the inhibition of PI3K-mediated signaling by
tensin2. Recently, tensin2 was identiﬁed as a critical factor required for
connecting the thrombopoietin receptor (c-Mpl) to the activation of
PI3K [43]. Thus, tensin2 may function as a scaffold to provide important
connections between PI3K and tyrosine kinases such as Axl, Syk and
Jak-2,with interactionsmadepossible through the clustering and tyrosine
phosphorylation of the associated kinases as shown for Syk in Fig. 5. Since
the overexpression of scaffolding proteins can inhibit signaling by seques-
tering signaling components into separate complexes (e.g., [44]), this
could potentially explain the negative effect of elevated levels of tensin2
on PI3K and Akt.
In conclusion, we have identiﬁed tensin2 as a novel Syk-interacting
protein that exhibits a unique mode of binding involving interactions
both dependent on and independent of tyrosine-phosphorylation.
When expressed in epithelial cells, Syk and tensin2 co-localize in
cytoplasmic clusters that lead to the aggregation and activation of the
kinase.
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